GlassScriptPhysician profile
Sarah Bowers
NPI 1932632510
$7,723.49
in general payments reported to CMS, 2019-2025
30 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $977 · 2022: $1,589 · 2023: $2,041 · 2024: $2,832 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,748 · Education: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,747.66 |
| Education | $410.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,738.73 | 2021-2025 | Tremfya |
| Abbvie INC. | $1,208.25 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $655.52 | 2021-2025 | Ilumya |
| Genzyme Corporation | $633.17 | 2021-2025 | |
| Leo Pharma INC. | $439.59 | 2021-2024 | Adbry |
| Novartis Pharmaceuticals Corporation | $419.91 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $359.56 | 2022-2024 | Dupixent, Libtayo |
| Lilly USA, LLC | $298.46 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $249.66 | 2021-2025 | Opzelura |
| Amgen INC. | $229.11 | 2021-2024 | Otezla |
| Verrica Pharmaceuticals INC. | $228.12 | 2024-2025 | Ycanth |
| Ucb, INC. | $174.78 | 2021-2024 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $168.85 | 2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $112.28 | 2023-2024 | Zoryve |
| Smith+Nephew, INC. | $92.13 | 2024 | Pico, Renasys Touch |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $89.40 | 2021-2025 | Aklief, Epsolay |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $87.80 | 2021-2025 | Cabtreo, Siliq, Jublia |
| Epi Health, LLC | $74.61 | 2021-2022 | |
| Journey Medical Corporation | $61.64 | 2021-2024 | |
| Dermavant Sciences, INC. | $55.07 | 2023-2024 | Vtama |
| Almirall LLC | $54.84 | 2024-2025 | Klisyri |
| Pfizer INC. | $46.44 | 2022-2023 | |
| Organon LLC | $44.81 | 2025 | |
| Medline Industries LP | $42.10 | 2024 | |
| Janssen Scientific Affairs, LLC | $34.99 | 2021 | |
| Genentech USA, INC. | $31.71 | 2021-2022 | |
| Dermira, INC. | $29.83 | 2021 | |
| Blueprint Medicines Corporation | $24.96 | 2024 | Ayvakit |
| Kyowa Kirin, INC. | $22.20 | 2024 | Poteligeo |
| Biofrontera INC. | $14.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.